Share on

Global Organ-on-Chip Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Type, Application & Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa) – Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 12347
Pages: 190
Formats: report pdf report excel report power bi report ppt

Global Organ-on-Chip Market Size (2022 to 2027)

The global organ-on-chip-market size is forecasted to be worth USD 284.65 million by 2027 from USD 60.29 million in 2022, registering a CAGR of 36.40% from 2022 to 2027.

An organ-on-a-chip (OOC) is a microfluidic cell culture device made with microchip manufacturing technologies that contain continuously perfused compartments populated by living cells and structured to mimic tissue and organ physiology. This chip creates a small channel for blood and air movement in organs like the lung, gut, liver, heart, and others. Using traditional 2D and 3D culture systems, such devices can develop different tissue and organ functionality levels. Organ-on-chip technology can be used for various purposes, including disease modeling, patient stratification, and phenotypic screening. Organs-on-chips, which simulate the physiology of human organs at the cellular level, is a viable alternative to animal models.

Impact of COVID-19 on the global organ-on-chip market:

Since the COVID-19 outbreak, the biopharmaceutical industry and the scientific community have become exceedingly proactive. As a result, Organ-on-chip has become one of the most adaptable technologies for generating medications and vaccines amid the pandemic. Simply put, the novel coronavirus has emerged as a profitable opportunity for the organ-on-a-chip sector, with constant growth expected during the forecast period.

MARKET DRIVERS:

Technological advancements and new product launches, a growing number of partnerships, and collaborations between pharmaceutical companies and organs-on-chips manufacturers are primarily promoting the global organ-on-chip market’s growth.

Researchers and scientists use Organ-on-chip culture systems to test the effects of various medications on the human body. Furthermore, this technology is used to analyze drug toxicity or effectiveness in various organs. The growing number of these processes is predicted to support the global organ-on-chip market. The ever-increasing focus on developing alternatives to animal testing models, a significant increase in research funding, and venture capital investments for the development of organs-on-chips are anticipated to boost the growth rate of the global organ-on-chip market. In addition, a growing need for early detection of drug toxicity to minimize financial risks is another significant factor driving the growth of this market.

Furthermore, with the healthcare sector increasing demand for advanced organ-on-chip technologies, it's expected that the market will continue to grow rapidly in the future years. Organ-on-chip technologies are primarily utilized for in-vitro biochemical analysis, real-time imaging, and metabolic and genetic activities of living cells in functional tissue. The continually expanding application breadth of OOCs is projected to drive demand for organs on chips during the forecast period. The growing prevalence of cardiovascular diseases (CVD) is likely to propel the organ-on-a-chip market to new heights. Organ-on-a-chip technologies were created to simulate the dynamic conditions of the circulatory system, particularly the heart and the general vasculature. Personalized medicine is a developing area that allows physicians to construct a targeted treatment for their patients, i.e., choosing the best possible medicines at the optimal dose depending on their specific needs. It has a massive opportunity for improving patient outcomes, especially in areas where a thorough grasp of each person's phenotypic and disease profile is critical. These patient-specific models aid in the prediction of toxicity and efficacy. Patients will be paired with the most appropriate medicines that will work for them in the future due to an emphasis on early disease identification and personalized medicine.

MARKET RESTRAINTS:

High production costs, as the costly redesigning process may be too much for the relatively tiny enterprises involved, may curb the organ-on-chip market growth.

Furthermore, developing bioreactors, pumps for perfusion of cell culture media, maintaining the cell environment, mechanical stimuli, and implementing cell analysis methods are difficult and expensive. Manufacturers of organs-on-chips are increasingly turning to big data to deal with the data created by OOCs. The data generated by OOCs can face several challenges, including sharing, integrating, and evaluating it. In addition, big data methods must be implemented on modern high-performance computing platforms to use the created data properly.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

By Type, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

 

This research report on the global organ-on-chip market has been segmented and sub-segmented based on type, application, and region.

Organ-on-chip market – By Type:

  • Heart-on-chip
  • Human-on-chip
  • Intestine-on-chip
  • Kidney-on-chip
  • Liver-on-chip
  • Lung-on-chip

Based on type, the lung-on-chip dominated the global organ-on-chip market in 2020 and is predicted to continue the same trend during the forecast period. Lung-on-chip technology is a complicated three-dimensional replica of a living, breathing human lung. This technology, which comprises human lung and blood vessel cells, can predict nanoparticle absorption and stimulate the inflammatory response induced by microbial infections. The device can also assess environmental contaminants, aerosolized treatments absorption, and the safety and efficacy of novel medications. Thus, it is anticipated that it will become a viable alternative to animal testing.

Organ-on-chip Market – By Application:

  • Drug Discovery
  • Toxicology Research
  • Other Applications

Drug discovery is expected to be the most popular segment, accounting for the largest share of the global market. As a result, pharmaceutical companies use OOCs widely for drug discovery and clinical trials in various chronic treatment areas.

Organ-on-chip Market – By Region:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

Geographically, North America is predicted to have the most significant share of the global organ-on-chip market and grow at the fastest CAGR. Because of the vast availability of extensive lines of services given by prominent organizations and the spike in chemicals' toxicity testing on various organ cells, America has emerged as the organ-on-chip market leader. In addition, private and public institutes invest a lot of money in extensive research, which adds to the region's market value.

Europe was ranked second worldwide in 2020 and is expected is accelerate at a prominent growth rate. The European market benefits from establishing multiple reputable OOC developers across Germany, the United Kingdom, Italy, Spain, and France, as well as government efforts and financing for research operations. Increased cooperation between corporations, institutes, and universities for the creation of higher-quality OOCs and the availability of well-established healthcare infrastructure are estimated to help the market grow in the next few years.

Due to the lucrative opportunities presented by nations like China, India, and Japan, Asia-Pacific is predicted to develop the fastest over the projection period. Furthermore, as the population's disposable income rises, the region's adoption of Organ-on-a-Chip technology is likely to increase. The expansion of the Organ-on-a-Chip market in the Asia-Pacific region is predicted to be supported by government support for regenerative medicines in research institutions and an increase in the number of cell-based clinical trials and investment in R&D activities.

KEY MARKET PARTICIPANTS:

Emulate, CN Bio Innovations, Tara Biosystems, Draper Laboratory, Mimetas, TissUse, Hesperos, Nortis, Micronit Microtechnologies B.V., Kirkstall, Cherry Biotech SAS, and Else Kooi Laboratory are some of the noteworthy companies operating in the global organ-on-chip market profiled in this report.

RECENT MARKET DEVELOPMENTS:

  • CN Bio, a famous creator of innovative single and multi-organ microphysiological systems or organ-on-a-chip, announced the release of their new PhysioMimix OOC Multi-Organ MPS in March 2021.
  • In 2020, CN Bio and Imperial College London will collaborate to use CN Bio's liver-on-chip technology to help researchers better understand the underlying mechanisms of alcoholic hepatitis and identify new therapeutic targets.
  • The license agreement for InSphero's Akura Flow organ-on-a-chip platform was announced in 2020 by InSphero AG and ETH Bio Engineering Laboratory.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample